25,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. ReciGen is the trade name of recombinant Interferon beta 1-a, which is manufactured as biosimilar/biogeneric as a liquid biomedicine in Iran.ReciGen is a type of Interferon beta which is used for multiple sclerosis (MS) therapy. Multiple sclerosis is the most common disease of the central nervous system. ReciGen is a glycoprotein and a Cytokine. Interferon beta-1a is a 22,500 Da glycoprotein, which has antiviral activity and regulates the immune system of the human…mehr

Produktbeschreibung
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. ReciGen is the trade name of recombinant Interferon beta 1-a, which is manufactured as biosimilar/biogeneric as a liquid biomedicine in Iran.ReciGen is a type of Interferon beta which is used for multiple sclerosis (MS) therapy. Multiple sclerosis is the most common disease of the central nervous system. ReciGen is a glycoprotein and a Cytokine. Interferon beta-1a is a 22,500 Da glycoprotein, which has antiviral activity and regulates the immune system of the human body. This product is made by recombinant technology and categorised as biomedicime and bosimilar. The amino acid sequence of this protein is the same as natural beta interferon. Both of these two proteins are glycosilated.